Tefé-Silva, C., Rodrigues, B.G., Pascoal, B.B., Minante, B.I., Vitoreli, B.C., de Sousa, B., arros, I.S.B., Fortunato, I.M. and de Castro, S.C. 2023. TRASTUZUMAB DERUXTECAN: NOVEL ANTIBODY-DRUG CONJUGATE TARGETING HER2 IN PATIENTS WITH GASTRIC ADENOCARCINOMA. Journal of Applied Pharmaceutical Sciences and Research. 5, 4 (Apr. 2023), 1-6. DOI:https://doi.org/10.31069/japsr.v5i4.01.